PIK3CA expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.261800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.880000E-01
Normal-vs-Stage2
5.902800E-01
Normal-vs-Stage3
6.361800E-02
Normal-vs-Stage4
7.554200E-01
Stage1-vs-Stage2
9.504200E-01
Stage1-vs-Stage3
1.898180E-01
Stage1-vs-Stage4
3.783200E-01
Stage2-vs-Stage3
7.278400E-03
Stage2-vs-Stage4
2.541000E-01
Stage3-vs-Stage4
1.367190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.731800E-01
Normal-vs-AfricanAmerican
8.805000E-01
Normal-vs-Asian
2.598200E-01
Caucasian-vs-AfricanAmerican
1.981770E-01
Caucasian-vs-Asian
3.554400E-01
AfricanAmerican-vs-Asian
1.358420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.124000E-01
Normal-vs-Female
5.601000E-01
Male-vs-Female
6.678000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.954400E-01
Normal-vs-Age(41-60Yrs)
9.820200E-01
Normal-vs-Age(61-80Yrs)
3.401600E-01
Normal-vs-Age(81-100Yrs)
2.439600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.431200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.962000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.018400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.555100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.212500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.074800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.292600E-01
Normal-vs-Daily Drinker
1.001020E-01
Normal-vs-Weekly Drinker
2.350600E-01
Normal-vs-Occasional Drinker
8.978400E-01
Normal-vs-Social Drinker
9.645400E-01
Non Drinker-vs-Daily Drinker
3.648800E-01
Non Drinker-vs-Weekly Drinker
7.955000E-01
Non Drinker-vs-Occasional Drinker
1.801820E-01
Non Drinker-vs-Social Drinker
1.281770E-01
Daily Drinker-vs-Weekly Drinker
5.817000E-01
Daily Drinker-vs-Occasional Drinker
6.802200E-02
Daily Drinker-vs-Social Drinker
5.398000E-02
Weekly Drinker-vs-Occasional Drinker
2.039600E-01
Weekly Drinker-vs-Social Drinker
1.444770E-01
Occasional Drinker-vs-Social Drinker
8.790200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.688400E-01
Normal-vs-Grade 2
5.308300E-02
Normal-vs-Grade 3
5.013800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.077500E-02
Grade 1-vs-Grade 3
1.126210E-02
Grade 1-vs-Grade 4
2.688400E-01
Grade 2-vs-Grade 3
4.031400E-01
Grade 2-vs-Grade 4
5.308300E-02
Grade 3-vs-Grade 4
5.013800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.859000E-01
Normal-vs-NonDiabetic
4.380400E-01
Diabetic-vs-NonDiabetic
8.575000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.406200E-01
Normal-vs-NoPancreatitis
4.736400E-01
Pancreatitis-vs-NoPancreatitis
9.951600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.347000E-01
Normal-vs-N1
6.071800E-01
N0-vs-N1
2.471800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.910200E-01
Normal-vs-TP53-NonMutant
4.958400E-01
TP53-Mutant-vs-TP53-NonMutant
1.640440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
